Valuation Unicycive Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 01/09/2026 BST			5-day change	1st Jan Change
5.050 ^USD	-2.88%		-7.68%	-12.48%

08-13	B. Riley Adjusts Price Target on Unicycive Therapeutics to $20 From $22, Maintains Buy Rating	MT
08-12	Unicycive Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30.84	8.148	30.16	82.44	124	140.7	-	-
Change	-	-73.58%	270.11%	173.36%	50.43%	13.44%	-	-
Enterprise Value (EV)	30.84	8.148	30.16	82.44	124	140.7	140.7	140.7
Change	-	-73.58%	270.11%	173.36%	50.43%	13.44%	0%	0%
P/E	-2.4x	-0.45x	-0.68x	-1.42x	-3.46x	-4.18x	3.13x	0.69x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	-0.1x	0x	0x	0.2x	-0x	0x
Capitalization / Revenue	-	8.57x	44.7x	-	-	511x	0.97x	0.29x
EV / Revenue	-	0x	0x	-	-	511x	0.97x	0.29x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-3.67x	2.87x	0.45x
EV / FCF	-0x	-	-0x	-0x	-0x	-4.32x	-6.8x	0.93x
FCF Yield	-18.8%	-	-60.7%	-34.8%	-25.3%	-23.2%	-14.7%	108%
Dividend per Share ²	-	-	-	-	-	-	2.08	5.37
Rate of return	-	-	-	-	-	-	41.2%	106%
EPS ²	-8.6	-12	-12.8	-5.6	-1.67	-1.209	1.614	7.35
Distribution rate	-	-	-	-	-	-	129%	73.1%
Net sales ¹	-	0.951	0.675	-	-	0.2754	145.4	487.7
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-8.977	-18.05	-20.77	-32.12	-29.52	-38.28	48.93	312.4
Net income ¹	-10.02	-18.06	-31.41	-37.82	-26.56	-34.12	46.27	296.9
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	20.600	5.400	8.677	7.942	5.770	5.050	5.050	5.050
Nbr of stocks (in thousands)	1,497	1,509	3,475	10,380	21,491	27,855	-	-
Announcement Date	31/03/22	31/03/23	28/03/24	31/03/25	30/03/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UNICYCIVE THERAPEUTICS, INC.	-4.18x	-	-	-	141M
WUXI APPTEC CO., LTD.	20.2x	7.1x	14.34x	1.44%	68.21B
ARGENX SE	36.48x	9.51x	29x	0.04%	64.25B
INSMED INCORPORATED	-74.38x	14.34x	-69.16x	-.--%	26.54B
BIONTECH SE	-15.61x	5.93x	-7.46x	-.--%	25.61B
GENMAB A/S	27.16x	5.09x	16.92x	-.--%	19.88B
PHARMAESSENTIA CORPORATION	49.41x	18.23x	36.98x	0.31%	17.13B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1290.27x	37.31x	814.28x	-.--%	14.93B
EXELIXIS, INC.	17.57x	5.23x	12.21x	-.--%	14.1B
MADRIGAL PHARMACEUTICALS, INC.	-85.32x	7.81x	-64.69x	-.--%	12.45B
Average	126.16x	12.28x	86.94x	0.2%	26.32B
Weighted average by Cap.	80.48x	10.52x	50.59x	0.4%